- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07654699
Active and Mindful - A Mind-Body Programme for People With Multiple Sclerosis: a Feasibility Study Protocol
The purpose of this exploratory study is to evaluate the feasibility and acceptability of the "Active and Mindful" home-based mind-body exercise program for individuals diagnosed with Multiple Sclerosis (MS) in Portugal and Spain.
Multiple Sclerosis often leads to physical and psychological challenges that impact health-related quality of life. Mind-body exercise programs combined with remote supervision present an accessible, flexible alternative to traditional center-based rehabilitation. This study assesses the practicality of implementing a 9-month online intervention delivered via video-conferencing, focusing on recruitment rates, retention, participant attendance, and overall satisfaction. Secondarily, the study explores pre-to-post changes in clinical and psychological indicators such as perceived physical exertion and health-related quality of life.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Background:
Multiple Sclerosis (MS) is a chronic, progressive neurological condition that requires ongoing management to maintain physical functioning and psychological well-being. Exercising at home using digital health solutions offers a viable pathway to increase adherence and overcome logistical barriers (such as transportation or geographic isolation) often faced by clinical populations. This exploratory study investigates the "Active and Mindful" program, a remotely supervised, home-based intervention designed specifically to accommodate the functional variations of people living with MS.
Objectives:
- To determine the feasibility of the program through quantitative benchmarks, specifically recruitment efficiency, attrition (retention rate), and global session attendance.
- To evaluate participant acceptability and satisfaction with the synchronous group dynamic.
- To collect preliminary exploratory data on patient-reported outcomes, including perceived exertion during sessions and health-related quality of life domains.
Methodology:
The study utilized a non-randomized, single-group, interventional design spanning a total duration of 9 months. Individuals with MS were recruited via digital interest forms and institutional channels across Portugal (in collaboration with the Sociedade Portuguesa de Esclerose Múltipla - SPEM) and Spain (in collaboration with the Asociación de Familiares y Afectados de Esclerosis Multiple - AFAEM).
The intervention was structured into distinct functional tiers to ensure physical safety and progressive adaptation:
- Synchronous Phase: Live, exercise sessions conducted via the ZOOM platform in small groups ranging from 3 to 8 participants, organized according to their baseline functional capacity. Sessions were held twice a week and incorporated physical fitness, adapted Pilates, Tai-Chi, mindfulness protocols, and guided relaxation techniques.
- Asynchronous Phase: During the latter half of the program, participants were progressively introduced to and integrated with digital video resources hosted on a dedicated web platform, promoting independent home practice.
- Session Monitoring: To assess the specific feasibility of these pre-recorded video sessions, participants completed study-specific session evaluation forms.
Data collection and Timeline:
Quantitative data and validated health surveys were administered at three distinct time points to capture the progression of the cohort:
- Baseline(T0): Collected before the first exercise session to record sociodemographic characteristics, clinical history, and initial status.
- Midpoint Assessment (T1): Conducted at approximately 4.5 months to monitor early compliance and initial shifts in perceived effort.
- Post-test (T2): Completed at month 9 to evaluate the terminal outcomes, overall compliance, retention metrics, and final system satisfaction.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Evora, Portugal, 7000-727
- Departamento de Desporto e Saúde, Escola de Saúde e Desenvolvimento Humano, Universidade de Évora
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Adult patients diagnosed with Multiple Sclerosis living in Portugal or Spain;
- Expanded Disability Status Scale (EDSS) score below 8;
- First to register on the online inscription survey (subject to limited spots)
- Time availability to comply with the session schedules;
- Access to compatible digital devices with visual feedback (Camera) and reliable internet connectivity;
- Ability to install and use the ZOOM platform with the camera turned on.
Exclusion Criteria:
- Significant medical comorbidities that impact or prevent safe exercise participation;
- Pregnant women.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Active and Mindful Mind-Body Exercise Group
People with Multiple Sclerosis participating in a remotely supervised, home-based mind-body exercise program
|
An online exercise program (combining synchronous and asynchronous sessions) conducted in a small groups (3 to 8 participants) tailored to functional levels.
Sessions were held twice a week for 9months, including physical fitness, Pilates, Tai-Chi, mindfulness, and relaxation techniques.
In the final phase, asynchronous video resources on a web platform were introduced
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Recruitment Rate
Prazo: Baseline (T0)
|
Percentage of participants recruited out of the total expressions of interest received.
|
Baseline (T0)
|
|
Retention Rate
Prazo: Post-intervention (T2 - 9 months)
|
Percentage of participants who completed the intervention and the final follow-up assessments
|
Post-intervention (T2 - 9 months)
|
|
Global Attendance Rate
Prazo: Through the 9 month intervention
|
Mean percentage of exercise sessions attended by the participants throughout the program.
|
Through the 9 month intervention
|
|
Program Satisfaction and Acceptability
Prazo: At the end of every training session throughout the 9-month intervention period.
|
Participant satisfaction scores measured through a feedback questionnaire (scored on a 1 to 5 Likert scale, where higher scores indicate higher satisfaction).
|
At the end of every training session throughout the 9-month intervention period.
|
|
Perceived Exertion (Borg RPE)
Prazo: At the end of every training session throughout the 9-month intervention period.
|
Assessment of physical effort intensity during exercise sessions using the Borg Rating of Perceived Exertion (RPE) scale 0-10.
Higher scores indicate higher physical exertion.
|
At the end of every training session throughout the 9-month intervention period.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
General Health-Related Quality of Life (SF-36)
Prazo: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Generic health status questionnaire covering 8 domains.
Subscale scores range from 0 to 100, where higher scores indicate better health status and quality of life.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Multiple Sclerosis-Specific Quality of Life (MSQOL-54)
Prazo: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Evaluation of MS-specific quality of life across physical and mental health composites.
Scores range from 0 to 100, where higher scores represent superior quality of life.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Modified Fatigue Impact Scale (MFIS)
Prazo: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Assessment of the impact of fatigue on physical, cognitive, and psychosocial functioning using the Modified Fatigue Impact Scale (MFIS).
Total score ranges from 0 to 84, where higher scores indicate a greater negative impact of fatigue.
Scores above 38 indicate significant clinical fatigue.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Anxiety and Depression Symptoms (HADS)
Prazo: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Evaluation of psychological distress using the Hospital Anxiety and Depression Scale (HADS), split into Anxiety (HADS-A) and Depression (HADS-D) subscales.
Each subscale scores from 0 to 21.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Activities-Specific Balance Confidence (ABC)
Prazo: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Self-reported scale measuring a patient's confidence in maintaining balance during various daily ambulatory activities.
Scores range from 0% to 100%, where higher percentages indicate greater balance confidence.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Mindfulness Attention Awareness Scale (MAAS)
Prazo: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Assessment of mindful presence and awareness in daily life using the Mindful Attention Awareness Scale (MAAS).
Total score ranges from 1 to 6 (calculated as a mean of items), where higher scores indicate higher dispositional mindfulness.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Interoceptive Awareness (MAIA)
Prazo: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Evaluation of body awareness and connection through the Multidimensional Assessment of Interoceptive Awareness (MAIA).
It measures 8 subscales scored from 0 to 5, with higher scores indicating better interoceptive awareness and body trusting.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Physical Activity Levels (IPAQ)
Prazo: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Assessment of total physical activity over the previous 7 days using the International Physical Activity Questionnaire (IPAQ).
Outcomes are reported as continuous scores in MET-minutes/week or categorized into Low, Moderate, or High activity groups.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
|
Pain Severity and Interference (BPI)
Prazo: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Evaluation of pain intensity and its impact on daily functional activities using the Brief Pain Inventory (BPI).
It generates two major subscales: Pain Severity (0-10) and Pain Interference (0-10), where higher scores denote worse pain and higher functional impairment.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
State Mindfulness (SMS)
Prazo: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Measurement of physical and mental mindfulness levels specifically experienced during or immediately after the intervention sessions using the State Mindfulness Scale (SMS).
Higher scores reflect greater state mindfulness.
|
Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)
|
Colaboradores e Investigadores
Publicações e links úteis
Links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Doenças do Sistema Nervoso
- Doenças autoimunes
- Doenças do sistema imunológico
- Doenças Autoimunes Desmielinizantes, SNC
- Doenças Autoimunes do Sistema Nervoso
- Doenças Desmielinizantes
- Esclerose múltipla
- Atividade motora
- Movimento
- Fenômenos fisiológicos musculoesqueléticos
- Fenômenos fisiológicos musculoesqueléticos e neurais
- Exercício
Outros números de identificação do estudo
- 101134389
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Active and Mindful Program
-
USDA Grand Forks Human Nutrition Research CenterCalifornia Polytechnic State University-San Luis ObispoConcluídoConsumo de frutas e vegetais | Nutrição infantil | Escolha de comida saudável | Preparação de Alimentos SaudáveisEstados Unidos
-
Haukeland University HospitalUniversity of Bergen; Norwegian University of Science and Technology; St. Olavs... e outros colaboradoresRecrutamentoTranstorno do Espectro AutistaNoruega